“Build What Matters, Govern With Integrity.”
Connor Copeland is a multidisciplinary executive who bridges engineering rigor, regulatory fluency, and policy-minded judgment to help organizations operate with excellence and scale with confidence. His career spans biomedical research, complex GMP manufacturing environments, and entrepreneurial real estate operations, all underscored by a commitment to advancing human health and strengthening institutions. He brings to boards and leadership teams a rare blend of hands-on technical depth and strategic, cross-functional perspective grounded in both science and law.
Connor’s professional journey began with a deep curiosity about how things work—cells, systems, organizations—and how thoughtful design can make them work better. He earned a Bachelor of Science in Bioengineering from California Lutheran University, graduating magna cum laude, where he paired technical training with minors in Political Science and Mathematics. That combination foreshadowed his career-long habit of toggling between the lab bench and the policy bench, seeing both the microstructure of a problem and the governance frameworks that determine how people will use, regulate, and fund the solution.
A formative chapter followed at Arizona State University, where Connor completed a Master of Science in Biomedical Engineering. He advanced research at the intersection of traumatic brain injury, neurodegeneration, and therapeutic delivery. He performed in vivo surgeries and behavioral studies, purified genetic material, and analyzed tissue through confocal immunohistochemistry and western blotting. He became fluent in tools like CellProfiler, ImageJ, and Prism, not as checkboxes on a skills list but as instruments to extract truth from complex biological data. That period culminated in peer-reviewed publications on nanoparticle-mediated drug delivery across the blood–brain barrier and sex-dependent transport after brain injury—contributions that refined his evidence-based approach to problem solving.
Connor’s research foundation set the stage for operational leadership in highly regulated, technically demanding settings. At Lonza, he served as an MSAT Scientist and helped stand up a new processing facility by designing unit operations, completing bioburden risk assessments, and converting technology transfers into workable, auditable manufacturing templates. He coordinated across teams to write and own GMP batch records, finalize drawings for single-use technologies, and facilitate the cross-disciplinary conversations that turn design intent into compliant execution. These were not abstract exercises in documentation; they were the operating system for quality, safety, and repeatability, and Connor treated them with the gravity they deserve.
Zoetis recruited Connor to apply that same systems mindset at greater scale. As a Process Engineer, he creates GMP batch records that both instruct frontline technicians and satisfy the scrutiny of global regulators. He confirms data accuracy and precision of language for regulatory submissions, trains teams to understand the scientific “why” behind each step, and models manufacturing processes to streamline future tech transfer. When inevitable deviations occur, he leads investigations to surface root causes and fix them at the level where they first arise—be that a sensor tolerance, a recipe ambiguity, or a missing handoff between functions. His remit spans the practical and the strategic: optimizing ongoing production while onboarding new products that must meet cost, quality, and time-to-market targets simultaneously.
A throughline in Connor’s career is the discipline of design. Whether he is building a nanoparticle, a batch record, or an investment thesis, he starts from first principles and works outward. At Celgene, he supported global research programs targeting under-researched diseases, running advanced automated systems, maintaining complex databases, and troubleshooting hardware and software to keep experiments flowing and results reliable. In each environment he has been a translator between worlds—scientists and operators, engineers and regulators, investors and tenants—bringing clarity where misalignment can be costly.
Connor’s policy sensibility is more than an academic footnote; it is an operating lens. As a Doctor of Law and Policy candidate at Liberty University, he studies constitutional frameworks and the role of the state in contemporary challenges. Earlier, while interning with the U.S. House of Representatives, he sat in hearings, digested legislative briefs, and drafted clear, concise recommendations—an early test of the same judgment he now applies to compliance questions and enterprise risk. He understands how rules are made, how they evolve, and how to align organizational behavior to both the letter and the spirit of the law.
Entrepreneurship rounds out his leadership profile. Connor co-owns and manages Highlanders Capital Three LLC, a real estate company through which he oversees multiple properties in Lincoln, Nebraska. He handles tenant relations, rent collection, budgeting, maintenance planning, and the everyday problem solving that comes with stewarding real assets and community relationships. The work is tactile and immediate—buildings, families, invoices—and it reinforces a conviction he carries into every boardroom: strategy only matters if it shows up in the details people live with day to day.
Colleagues recognize Connor for a steady, improvement-driven temperament. He thrives in ambiguity, yet insists on measurable outcomes. He is comfortable drafting a policy memo in the morning, troubleshooting a processing deviation at noon, and negotiating a vendor contract in the afternoon—then turning those lessons into a clearer playbook for the teams he supports. His leadership impact shows up in fewer surprises, faster transfers, tighter documentation, and a culture that treats quality as everyone’s job.
Connor’s technical fluency spans GMP operations, sterile techniques, analytical methods, and advanced automation platforms. He is conversant in SAP and LIMS, has experience with SolidWorks and data analysis, and able to pressure-test models from both the scientific and financial angles. But what differentiates him is not the breadth of tools; it is his habit of using them to serve a purpose bigger than any tool—patient safety, customer trust, institutional legitimacy, and the compounding value of continuous improvement.
Education and recognition have accompanied this trajectory. In addition to his master’s degree from ASU and undergraduate honors at CLU, Connor has earned fellowships and awards that reflect merit and momentum. He has published in respected journals, contributed to work on platelet-like particles and post-injury inflammation, and filed a patent for an innovative infant carrier with integrated pumping and storage—evidence that he sees unmet needs in the real world and designs practical solutions.
At core, Connor Copeland is animated by service: to patients who rely on quality, to teams who deserve clarity, to communities that need reliable housing, and to institutions that depend on principled governance. He seeks opportunities where his cross-disciplinary experience—engineering, policy, operations, and entrepreneurship—can strengthen oversight, accelerate innovation, and keep organizations accountable to the people they exist to help.
Character:
Connor leads with calm accountability, doing what he says he will do and taking ownership when systems fall short. He treats colleagues and partners with respect, believing that integrity compounds faster than any shortcut. He balances urgency with care, ensuring the right thing is done the right way, even when no one is watching.
Knowledge:
He integrates scientific method, GMP practice, and legal-policy analysis into a coherent decision framework. He keeps current on manufacturing technologies and regulatory expectations, translating complexity into actionable guidance for teams. He learns quickly across domains and turns that learning into durable institutional knowledge.
Strategic:
Connor connects day-to-day operations to multi-year objectives, aligning resources with measurable outcomes. He designs processes that scale, building feedback loops that reduce defects and accelerate compliant tech transfer. He evaluates risk holistically—technical, regulatory, financial—and chooses paths that preserve optionality while driving progress.
Communication:
He writes clearly, documents precisely, and communicates the “why” behind every “what,” enabling better choices at every level. He is an effective translator between scientists, operators, executives, and regulators, ensuring alignment across disciplines. He listens first, synthesizes second, and speaks last, creating space for the best ideas to emerge.
